SCHEMBL8285269

SCHEMBL8285269

CC(=O)N(Cc1cc(C(F)(F)F)c2c(=O)cc(Nc3ccccc3)n(-c3ccccc3)c2n1)c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE11A Q9HCR9 1/20 0.54
CNR1 P21554 2/20 0.35
CNR2 P34972 2/20 0.35
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
WEE1 P30291 1/20 0.33
NPY5R Q15761 1/20 0.32
ALDH1A1 P00352 2/20 0.32
LMNA P02545 1/20 0.32
MAPT P10636 1/20 0.32
HTT P42858 1/20 0.32
NPSR1 Q6W5P4 1/20 0.31
HDAC6 Q9UBN7 1/20 0.31
POLB P06746 1/20 0.31
GAA P10253 1/20 0.31
RIPK1 Q13546 1/20 0.31
PIK3CD O00329 1/20 0.31
PIK3R2 O00459 1/20 0.31
PIK3CG P48736 1/20 0.31
POLQ O75417 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8285283 0.88 PDE11A (0.57) PDE11ACNR1CNR2MEN1KMT2A
SCHEMBL8285270 0.85 PDE11A (0.58) PDE11ACNR1CNR2MEN1KMT2A
SCHEMBL8285257 0.84 PDE11A (0.57) PDE11ACNR1CNR2MEN1KMT2A
SCHEMBL8285254 0.82 PDE11A (0.59) PDE11ACNR1CNR2MEN1KMT2A
SCHEMBL8285258 0.82 PDE11A (0.55) PDE11ACNR1CNR2MEN1KMT2A
SCHEMBL8285287 0.81 PDE11A (0.63) PDE11ACNR1CNR2MEN1KMT2A
SCHEMBL8287847 0.81 PDE11A (0.60) PDE11ACNR1CNR2MEN1KMT2A
SCHEMBL8287476 0.81 PDE11A (0.56) PDE11ACNR1CNR2MEN1KMT2A
SCHEMBL8285280 0.81 PDE11A (0.56) PDE11ACNR1CNR2MEN1KMT2A
SCHEMBL8362903 0.81 PDE11A (0.56) PDE11ACNR1CNR2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed